Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation

Saved in:
Bibliographic Details
Published inLeukemia Vol. 36; no. 1; pp. 267 - 270
Main Authors Zhao, Xiang-Yu, Xu, Zheng-Li, Mo, Xiao-Dong, Chen, Yu-Hong, Lv, Meng, Cheng, Yi-Fei, Chen, Huan, Chang, Ying-Jun, Xu, Lan-Ping, Wang, Yu, Zhang, Xiao-Hui, Liu, Kai-Yan, Huang, Xiao-Jun
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2022
Nature Publishing Group
Subjects
692/308/2779/109/1940
692/699/1541/1990/283/2125
Adolescent
Adult
Antigens, CD19 - immunology
Blood diseases
Cancer Research
CD19 antigen
Chemotherapy
Child
Critical Care Medicine
Female
Follow-Up Studies
Hematology
Hematopoietic Stem Cell Transplantation - methods
Hematopoietic stem cells
Humans
Immunotherapy, Adoptive - methods
Intensive
Internal Medicine
Letter
Leukemia
Lymphocytes T
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Recurrence, Local - immunology
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - therapy
Neoplasm, Residual - immunology
Neoplasm, Residual - pathology
Neoplasm, Residual - therapy
Oncology
Patients
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy
Preempting
Prognosis
Prospective Studies
Remission (Medicine)
Remission Induction
Stem cell transplantation
Stem cells
Tissue Donors
Transplantation
Young Adult
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0887-6924
1476-5551
1476-5551
DOI:10.1038/s41375-021-01351-w